ピクシーダストテクノロジーズ株式会社の社外取締役に髙橋政代氏が就任しました
髙橋政代氏には、豊富な知識や経験を活かし、PxDTの経営に対する監督およびサービス・技術全般の助言をしていただきます。PxDTは、今後も従来の医療アプローチでは対応できなかった世界中のアンメットニーズに応えるため、独自の波動制御技術を用いた非接触・非侵襲の「新しい選択肢」を提供してまいります。
- 髙橋政代氏 就任の背景
* メカノバイオロジーとは、細胞や生体組織に力が作用したときの応答について調べる研究分野をいいます。
- 髙橋政代氏 コメント
落合陽一さんとTED x TokyoやGoogleのSci Foo Campなどで接点があり、その後聴覚障害のためのデバイスなど開発されていることを知りました。先端科学を基盤として社会利益を視野に入れた素早い事業展開が魅力で、これまでの経験を生かしてお役に立てるなら嬉しいことと思います。
- PxDT代表取締役落合陽一 コメント
髙橋政代さんのご活躍の折に触れ、産学連携や研究の社会実装について同じ志を持っていることを確信してきました。ご参画によって弊社プロダクトの信頼性の向上や社会実装への進展に対し大きな好影響があると信じています。
- 髙橋政代氏 略歴
1986年、京都大学医学部卒業、1992年同大学大学院医学研究科修了。医学博士。
京都大学医学部附属病院眼科助手を経て、1996年にソーク研究所に移り、幹細胞を用いた網膜治療の可能性を見出す。2006年に理化学研究所に入社、2013年にヒトで初めてiPS細胞を用いた臨床研究を開始した。2017年、神戸市立眼科病院研究センター長に就任。2019年、臨床治療を進めるため、スタートアップ企業である株式会社ビジョンケアの代表取締役として新たなキャリアをスタート。
- ピクシーダストテクノロジーズ株式会社について
私たちピクシーダストテクノロジーズ株式会社は、東京に本社を置き、ヒューマンインターフェースとホログラムと波動現象の学術的バックグラウンド（博士・教授歴）を持つ2人の研究者を中心に創業されました。特にデジタル超音波制御については世界一優れていると強く確信している会社です。
私たちは、「吸音メタマテリアル」や「五感を介した認知症介護」や「超音波によるメカノバイオロジーによるヘルスケア」など、従来のユーザーインターフェースや医療機器によるアプローチを超えた、世界中のアンメットニーズに応えるための「新しい選択肢」を提供する技術企業です。超音波だけでなく、光やいわゆる電磁波も操れ「波動制御技術（計算機ホログラム技術や信号処理技術）」に特化したコア技術を持ち、オフィス領域、ヘルスケアやダイバーシティ分野における非接触・非侵襲デバイスの開発を中心に、「QOL向上」「身体能力の補完・向上」「加齢への対応」をメインドメインとし、そのための技術開発を進めています。
===
Dr. Masayo Takahashi has been appointed as an outside director of Pixie Dust Technologies, Inc.
Pixie Dust Technologies, Inc. (headquartered in Chiyoda-ku, Tokyo; Representative Directors: Yoichi Ochiai, Taiichiro Murakami; hereinafter "PxDT") announces that Dr. Masayo Takahashi has been appointed as an outside director at the fifth General Meeting of Shareholders held on July 27, 2022. Dr. Takahashi will utilize a wealth of knowledge and experience to oversee PxDT´s management and provide advice on services and technology. PxDT will continue to offer "new option" of non-contact and non-invasive approaches to cater to unmet needs that cannot be addressed by conventional medical approaches using its proprietary wave control technology.
Background of Appointment of Dr. Masayo Takahashi
PxDT focuses on research and development in the healthcare field, including "dementia care through the five senses" and "healthcare through Mechanobiology* with ultrasound." Having Dr. Masayo Takahashi, who has extensive knowledge and experience in advanced medicine and medical ethics as a clinician and a researcher as well as an executive of a company developing retinal treatment, participate in the management as an outside director, PxDT will build an even stronger management structure and accelerate growth in the healthcare field.
* Mechanobiology is a field of research that investigates responses of cells and living tissues when force is applied.
Comment from Dr. Masayo Takahashi
I met Dr. Yoichi Ochiai through TED x Tokyo and Google´s Sci Foo Camp, and later learned that he was developing a device for deaf and hard of hearing people. I am highly interested in his quick business development based on cutting-edge technology with an eye on social benefit, and I would be very happy if I could provide help by making use of my experience.
Comment from Yoichi Ochiai, CEO of PxDT
I have been convinced by Dr. Masayo Takahashi´s initiatives that she shares the same aspirations for the industry-academia collaboration and social implementation of research. I believe her participation will have a significant positive impact on improvement of the reliability of our products and progress of social implementation.
Profile of Dr. Masayo Takahashi, M.D.
Masayo Takahashi received her M.D. in 1986, and her Ph.D. in 1992, from Kyoto University. After an assistant professorship in the Department of Ophthalmology, Discovered the potential of stem cells as a tool for retina therapy when she worked at the Salk Institute, U.S. She joined RIKEN in 2006, her team launched a pilot clinical study using iPS cells first in human in 2013. In 2017, she was appointed to the research center director of Kobe City Eye Hospital. In 2019, she started a new career, a president of start-up company; Vision Care Inc., to proceed implement clinical therapy.
About Pixie Dust Technologies, Inc.
We, Pixie Dust Technologies Inc. are headquartered in Tokyo, Japan, and were founded by two researchers with academic backgrounds (Ph.D. and professorship) in human interface, holograms and wave control technology. We strongly believe that our company has the world´s best in the field of digital ultrasonic control. We are a technology company that offers "new options" to meet unmet needs around the world beyond the traditional user interface and medical device approaches, such as "sound-absorbing metamaterials," "dementia care through the five senses," and "healthcare through mechanobiology using ultrasound". With its core technology specialized in "wave control technology (computational hologram technology and signal processing technology)" that can manipulate not only ultrasound but also light and so-called electromagnetic waves, the company focuses on the development of non-contact, non-invasive products for the office, healthcare, and diversity fields, with a focus on "improving quality of life," "complementing and improving physical capabilities," and "coping with aging. We are developing technologies for "quality of life," "enhancement of bodily functions," and "response to aging," as our main domain.
すべての画像
